-

Hims & Hers Expands Customizable, Compounded Skincare Offerings With Hims Overnight Anti-Aging Duo, Hers Clear Skin System

New offerings include a personalized, compounded prescription cream to ensure high clinical efficacy

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.

“Skincare is a lifelong journey and certainly not a one-size-fits-all proposition,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “We have worked hand-in-hand with experienced dermatologists to offer customizable prescription creams that can be used both individually and in combination with other Hims & Hers skincare offerings so our customers have the opportunity to experience their best skin possible.”

Hims Overnight Anti-Aging Duo was developed with dermatologists to combat wrinkles and sun damage while moisturizing and nourishing skin. It includes a customizable prescription Anti-Aging Cream mixed with three clinical ingredients and available in three different strengths, as well as the nonprescription Goodnight Wrinkle Cream made with hyaluronic acid. Both the customizable prescription Anti-Aging Cream and Goodnight Wrinkle Cream will also continue to be available for purchase individually on ForHims.com. Those consumers looking to purchase the prescription cream -- as part of the Duo or individually -- will need to first complete a consultation with a healthcare provider through the Hims & Hers platform to see if a prescription treatment is medically recommended and will be able to purchase the prescription cream only if deemed appropriate by the healthcare provider. The Goodnight Wrinkle Cream is available for purchase directly from Hims without a prescription.

Hers’ Clear Skin System provides consumers with the ability to have both clean and hydrated skin with the support of an experienced medical professional. If appropriate, customers can receive a customizable prescription acne cream tailored to their individual needs with a blend of up to five powerhouse ingredients: tretinoin, clindamycin, azelaic acid, zinc pyrithione and niacinamide, as well as the Deep Sea Cleanser, a gentle, hydrating cleanser made with red seaweed extract and rosehip; and the Tidal Wave Moisturizer, made with hyaluronic acid and squalane to hydrate without clogging pores.

For more information on Hims skincare, please visit https://www.forhims.com/skin-care and on Hers skincare, please visit https://www.forhers.com/skin-care.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers, a multi-specialty telehealth platform, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...

Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, refe...

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...
Back to Newsroom